Evidence map›Paper›PMID 39057296›Full record

ArticleJournal of functional biomaterials2024

Optimizing Filament-Based TCP Scaffold Design for Osteoconduction and Bone Augmentation: Insights from In Vivo Rabbit Models.

Julien Guerrero, Ekaterina Maevskaia, Chafik Ghayor, Indranil Bhattacharya, Franz E Weber

Abstract read
In one paragraph

Article in Journal of functional biomaterials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julien GuerreroCenter of Dental Medicine, Oral Biotechnology & Bioengineering, University of Zurich, 8032 Zurich, Switzerland.ORCID 0000-0003-4130-4230
Ekaterina MaevskaiaCenter of Dental Medicine, Oral Biotechnology & Bioengineering, University of Zurich, 8032 Zurich, Switzerland.
Chafik GhayorCenter of Dental Medicine, Oral Biotechnology & Bioengineering, University of Zurich, 8032 Zurich, Switzerland.ORCID 0000-0002-3016-3412
Indranil BhattacharyaCenter of Dental Medicine, Oral Biotechnology & Bioengineering, University of Zurich, 8032 Zurich, Switzerland.
Franz E WeberCenter of Dental Medicine, Oral Biotechnology & Bioengineering, University of Zurich, 8032 Zurich, Switzerland.ORCID 0000-0003-1670-2296

Funding

Swiss National Science Foundation 310030_197128
6 · The paper itself

Abstract

Additive manufacturing has emerged as a transformative tool in biomedical engineering, offering precise control over scaffold design for bone tissue engineering and regenerative medicine. While much attention has been focused on optimizing pore-based scaffold architectures, filament-based microarchitectures remain relatively understudied, despite the fact that the majority of 3D-printers generate filament-based structures. Here, we investigated the influence of filament characteristics on bone regeneration outcomes using a lithography-based additive manufacturing approach. Three distinct filament-based scaffolds (Fil050, Fil083, and Fil125) identical in macroporosity and transparency, crafted from tri-calcium phosphate (TCP) with varying filament thicknesses and distance, were evaluated in a rabbit model of bone augmentation and non-critical calvarial defect. Additionally, two scaffold types differing in filament directionality (Fil and FilG) were compared to elucidate optimal design parameters. Distance of bone ingrowth and percentage of regenerated area within scaffolds were measured by histomorphometric analysis. Our findings reveal filaments of 0.50 mm as the most effective filament-based scaffold, demonstrating superior bone ingrowth and bony regenerated area compared to larger size filament (i.e., 0.83 mm and 1.25 mm scaffolds). Optimized directionality of filaments can overcome the reduced performance of larger filaments. This study advances our understanding of microarchitecture's role in bone tissue engineering and holds significant implications for clinical practice, paving the way for the development of highly tailored, patient-specific bone substitutes with enhanced efficacy.

Indexed as

additive manufacturingbone regenerationbone substitutebone tissue engineeringceramicsfilament-based scaffoldsmicroarchitectureosteoconductiontri-calcium phosphatevertical bone augmentation

Identifiers

PMID39057296
PMCPMC11278252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.